Stay updated on Paltusotine Safety/Efficacy in Acromegaly: Clinical Trial
Sign up to get notified when there's something new on the Paltusotine Safety/Efficacy in Acromegaly: Clinical Trial page.

Latest updates to the Paltusotine Safety/Efficacy in Acromegaly: Clinical Trial page
- Check3 days agoChange DetectedThe footer’s ClinicalTrials.gov revision identifier was updated from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedAn NIH-wide notice about the transition from “Artificial Intelligence” to “Super Intelligence” appears above the 403 error page. The site revision advances from v3.7.1 to v3.7.2.SummaryDifference1%

- Check31 days agoChange DetectedThe footer’s site revision label changes from v3.7.0 to v3.7.1, while the page continues to display a 403 error.SummaryDifference0.2%

- Check45 days agoChange DetectedThe page now loads a 403 Forbidden screen, replacing the study details with a standard error page. This indicates restricted access to the study record rather than showing its content.SummaryDifference18%

- Check52 days agoChange DetectedPage revision updated from v3.6.6 to v3.7.0, signaling a maintenance update to the page version. This update changes only the metadata tag and does not modify study information or user-facing content.SummaryDifference0.1%

- Check66 days agoChange DetectedRevision tag at the bottom changed from v3.6.5 to v3.6.6, indicating a newer page version. This appears to be a minor update to the page's release version rather than a substantive content change.SummaryDifference0.1%

Stay in the know with updates to Paltusotine Safety/Efficacy in Acromegaly: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Paltusotine Safety/Efficacy in Acromegaly: Clinical Trial page.